SEC Form 4 · accession 0000911916-15-000191

CoLucid Pharmaceuticals, Inc. · CLCD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — VP-Research and Development

Period of report

May 13, 2015

Accepted (ET)

May 13, 2015 · 4:35 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001348649

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	May 13, 2015	M	2,457	$4.07	A	2,457	D
Common Stock	May 13, 2015	M	2,457	$4.07	A	4,914	D
Common Stock	May 13, 2015	M	5,541	$5.09	A	10,455	D
Common Stock	May 13, 2015	M	3,690	$5.09	A	14,145	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Employee Stock Option (Right to Buy)^F1	$4.07	May 13, 2015	M	2,457	D	—	Apr 20, 2016	Common Stock	2,457	D
Employee Stock Option (Right to Buy)^F2	$4.07	May 13, 2015	M	2,457	D	—	Jun 26, 2017	Common Stock	2,457	D
Employee Stock Option (Right to Buy)^F3	$5.09	May 13, 2015	M	5,541	D	—	Jul 15, 2018	Common Stock	5,541	D
Employee Stock Option (Right to Buy)^F4	$5.09	May 13, 2015	M	3,690	D	—	Feb 2, 2019	Common Stock	3,690	D

F1This option vested as follows: 614 shares vested on February 20, 2007, and the remaining 1,843 shares vested in equal monthly installments on the last day of each month, beginning March 31, 2007, over the following 36 months.
F2This option vested as follows: 614 shares vested on June 27, 2008, and the remaining 1,843 shares vested in equal monthly installments on the last day of each month, beginning July 31, 2008, over the following 36 months.
F3This option vested as follows: 1,385 shares vested on June 6, 2009, and the remaining 4,156 shares vested in equal monthly installments on the last day of each month, beginning June 30, 2009, over the following 36 months.
F4This option vested in portions between June 6, 2009 and May 31, 2012.